(Q46885397)

26 December 2017

title

Effect of voriconazole on the pharmacokinetics of diclofenac (English)

1 reference

26 December 2017

1 reference

1 reference

1 reference

2

1 reference

26 December 2017

Pertti J. Neuvonen

5

1 reference

26 December 2017

author name string

Ville-Veikko Hynninen

1

1 reference

26 December 2017

Kari Leino

3

1 reference

26 December 2017

Stefan Lundgren

4

1 reference

26 December 2017

Anders Rane

6

1 reference

26 December 2017

Mika Valtonen

7

1 reference

26 December 2017

Kari Laine

8

1 reference

26 December 2017

publication date

1 December 2007

1 reference

26 December 2017

Fundamental and Clinical Pharmacology

published in

1 reference

26 December 2017

volume

21

1 reference

26 December 2017

issue

6

1 reference

26 December 2017

page(s)

651-656

1 reference

26 December 2017

Bioavailability of diclofenac potassium at low doses

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2007.00516.X

Hepatic metabolism of diclofenac: role of human CYP in the minor oxidative pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2007.00516.X

Voriconazole potentiates warfarin‐induced prothrombin time prolongation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2007.00516.X

Coadministration of voriconazole and phenytoin: pharmacokinetic interaction, safety, and toleration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2007.00516.X

Effect of voriconazole on the pharmacokinetics and pharmacodynamics of intravenous and oral midazolam.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2007.00516.X

Development and validation of a high-performance liquid chromatography assay for voriconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2007.00516.X

Effects of the antifungals voriconazole and fluconazole on the pharmacokinetics of s-(+)- and R-(-)-Ibuprofen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2007.00516.X

Extrapolation of diclofenac clearance from in vitro microsomal metabolism data: role of acyl glucuronidation and sequential oxidative metabolism of the acyl glucuronide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2007.00516.X

Characterization of rat and human UDP-glucuronosyltransferases responsible for the in vitro glucuronidation of diclofenac

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2007.00516.X

Quantitative prediction of in vivo inhibitory interactions involving glucuronidated drugs from in vitro data: the effect of fluconazole on zidovudine glucuronidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2007.00516.X

Influence of age and cytochrome P450 2C9 genotype on the steady-state disposition of diclofenac and celecoxib

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2007.00516.X

Pharmacokinetics of diclofenac and inhibition of cyclooxygenases 1 and 2: no relationship to the CYP2C9 genetic polymorphism in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2007.00516.X

The role of CYP2C9 genotype in the metabolism of diclofenac in vivo and in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2007.00516.X

Cardiovascular outcomes in new users of coxibs and nonsteroidal antiinflammatory drugs: high-risk subgroups and time course of risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2007.00516.X

10.1111/J.1472-8206.2007.00516.X

21 January 2018

Identifiers

DOI

1 reference

26 December 2017

PubMed ID

18034666

1 reference

26 December 2017